Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials.

PubWeight™: 1.58‹?› | Rank: Top 4%

🔗 View Article (PMID 14742976)

Published in Transplantation on January 27, 2004


Angela C Webster1, E Geoffrey Playford, Gail Higgins, Jeremy R Chapman, Jonathan C Craig

Author Affiliations

1: Cochrane Renal Group, Centre for Kidney Research, Children's Hospital at Westmead, Westmead, NSW, Australia.

Articles citing this

Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta. Proc Natl Acad Sci U S A (2004) 2.37

Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients. J Am Soc Nephrol (2009) 2.08

Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence. Am J Ophthalmol (2008) 1.56

First-in-human study of the safety and efficacy of TOL101 induction to prevent kidney transplant rejection. Am J Transplant (2014) 1.41

Daclizumab therapy for multiple sclerosis. Neurotherapeutics (2013) 1.33

Current landscape for T-cell targeting in autoimmunity and transplantation. Immunotherapy (2011) 1.02

Current concepts and perspectives of immunosuppression in organ transplantation. Langenbecks Arch Surg (2007) 0.94

Anti-interleukin-2 receptor antibodies-basiliximab and daclizumab-for the prevention of acute rejection in renal transplantation. Biologics (2009) 0.93

The efficacy and safety of daclizumab and its potential role in the treatment of multiple sclerosis. Ther Adv Neurol Disord (2014) 0.89

Regression of advanced melanoma upon withdrawal of immunosuppression: case series and literature review. Med Oncol (2009) 0.88

The CLEAR study: a 5-day, 3-g loading dose of mycophenolate mofetil versus standard 2-g dosing in renal transplantation. Clin J Am Soc Nephrol (2010) 0.84

Immunosuppressive drug therapy. Cold Spring Harb Perspect Med (2013) 0.83

Antibody induction therapy in adult kidney transplantation: A controversy continues. World J Transplant (2012) 0.81

Near-term anti-CD25 monoclonal antibody administration protects murine liver from ischemia-reperfusion injury due to reduced numbers of CD4+ T cells. PLoS One (2014) 0.80

Efficacy of basiliximab induction in poorly matched living donor renal transplantation. Indian J Nephrol (2013) 0.80

Basiliximab induction therapy for live donor kidney transplantation: a long-term follow-up of prospective randomized controlled study. Clin Exp Nephrol (2008) 0.80

Short-term anti-CD25 monoclonal antibody administration down-regulated CD25 expression without eliminating the neogenetic functional regulatory T cells in kidney transplantation. Clin Exp Immunol (2009) 0.79

The role of basiliximab in the evolving renal transplantation immunosuppression protocol. Biologics (2008) 0.78

Impact of Immune-Modulatory Drugs on Regulatory T Cell. Transplantation (2016) 0.77

Chronic allograft nephropathy in paediatric renal transplantation. Pediatr Nephrol (2006) 0.77

Cost-Effectiveness of Antibody-Based Induction Therapy in Deceased Donor Kidney Transplantation in the United States. Transplantation (2016) 0.76

Effects of interleukin 2 receptor blockers on patient and graft survival in renal-transplanted children. Nephrourol Mon (2014) 0.75

Transplantation: Personalizing induction therapy in kidney transplantation. Nat Rev Nephrol (2009) 0.75

Interleukin receptor antagonist induction in kidney transplantation: Is it worth the price? Indian J Nephrol (2013) 0.75

Basiliximab induction therapy in kidney transplantation: benefits for long term allograft function after 10 years? Biologics (2009) 0.75

Heterogeneity of induction therapy in Spain: changing patterns according to year, centre, indications and results. NDT Plus (2010) 0.75

Preemptive kidney transplantation: a propensity score matched cohort study. Clin Exp Nephrol (2016) 0.75

The contribution of systematic reviews to the practice of pediatric nephrology. Pediatr Nephrol (2012) 0.75

Articles by these authors

A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med (2010) 10.33

The natural history of chronic allograft nephropathy. N Engl J Med (2003) 8.70

Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev (2012) 6.38

Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis (2007) 5.84

Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA (2011) 5.54

Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med (2009) 4.90

Cancer incidence before and after kidney transplantation. JAMA (2006) 4.77

Meta-analysis: vitamin D compounds in chronic kidney disease. Ann Intern Med (2007) 4.23

Long-term survival of children with end-stage renal disease. N Engl J Med (2004) 4.10

Clinical trials in children. Lancet (2004) 3.97

Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med (2012) 3.78

Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med (2012) 3.62

Acute rejection, T-cell-depleting antibodies, and cancer after transplantation. Transplantation (2014) 3.40

Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ (2008) 3.35

The number, quality, and coverage of randomized controlled trials in nephrology. J Am Soc Nephrol (2004) 3.30

Diagnostic accuracy of urine dipsticks for detection of albuminuria in the general community. Am J Kidney Dis (2011) 3.29

Strategies for increasing recruitment to randomised controlled trials: systematic review. PLoS Med (2010) 3.18

How can we achieve global equity in provision of renal replacement therapy? Bull World Health Organ (2008) 3.00

Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med (2010) 2.97

KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int (2009) 2.72

Cost-effectiveness of initiating dialysis early: a randomized controlled trial. Am J Kidney Dis (2011) 2.62

Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation (2013) 2.55

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev (2014) 2.35

Screening and follow-up of living kidney donors: a systematic review of clinical practice guidelines. Transplantation (2011) 2.34

Parents' attitudes to children's participation in randomized controlled trials. J Pediatr (2003) 2.26

Haemoglobin targets: we were wrong, time to move on. Lancet (2007) 2.26

Role of blood pressure targets and specific antihypertensive agents used to prevent diabetic nephropathy and delay its progression. J Am Soc Nephrol (2006) 2.24

Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol (2013) 2.22

HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev (2013) 2.21

Fluid and nutrient intake and risk of chronic kidney disease. Nephrology (Carlton) (2011) 2.18

Antibiotics for acute pyelonephritis in children. Cochrane Database Syst Rev (2014) 2.17

Accuracy of the "traffic light" clinical decision rule for serious bacterial infections in young children with fever: a retrospective cohort study. BMJ (2013) 2.14

Measuring the quality of public open space using Google Earth. Am J Prev Med (2011) 2.11

Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials. Lancet (2005) 2.09

Enteral vs intravenous rehydration therapy for children with gastroenteritis: a meta-analysis of randomized controlled trials. Arch Pediatr Adolesc Med (2004) 2.03

Pediatricians' attitudes toward randomized controlled trials involving children. J Pediatr (2002) 2.01

Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data. BMJ (2009) 2.00

Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: implications for clinical practice. Clin Chem Lab Med (2015) 1.98

Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies. Am J Kidney Dis (2009) 1.94

Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review. BMJ (2004) 1.92

Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data. BMJ (2005) 1.90

Vitamin D compounds for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev (2009) 1.88

The role of surveillance chest X-rays in the follow-up of high-risk melanoma patients. Ann Surg Oncol (2008) 1.87

Prevention of peripheral intravenous catheter-related bloodstream infections: the need for a new focus. Med J Aust (2013) 1.85

Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology. Transplantation (2004) 1.82

Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies. Am J Kidney Dis (2010) 1.81

Chronic allograft nephropathy: current concepts and future directions. Transplantation (2006) 1.79

Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol (2002) 1.79

The motivations and experiences of living kidney donors: a thematic synthesis. Am J Kidney Dis (2012) 1.78

Comparative accuracy of renal duplex sonographic parameters in the diagnosis of renal artery stenosis: paired and unpaired analysis. AJR Am J Roentgenol (2007) 1.77

Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii. Clin Infect Dis (2013) 1.76

The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients. Kidney Int (2013) 1.75

Support interventions for caregivers of people with chronic kidney disease: a systematic review. Nephrol Dial Transplant (2008) 1.74

Evidence-based management of steroid-sensitive nephrotic syndrome. Pediatr Nephrol (2005) 1.72

Long-term antibiotics for preventing recurrent urinary tract infection in children. Cochrane Database Syst Rev (2011) 1.69

Risk factors for nocturnal enuresis in school-age children. J Urol (2009) 1.68

Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials. Transplantation (2006) 1.63

Biocompatible dialysis fluids for peritoneal dialysis. Cochrane Database Syst Rev (2014) 1.63

Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: a prospective open-label randomized controlled trial in nonresponders to primary vaccination. Am J Kidney Dis (2009) 1.61

Interventions for primary vesicoureteric reflux. Cochrane Database Syst Rev (2011) 1.58

Association of CKD and cancer risk in older people. J Am Soc Nephrol (2009) 1.57

Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis. Cochrane Database Syst Rev (2014) 1.55

4. Bedwetting and toileting problems in children. Med J Aust (2005) 1.54

Experiences and perspectives of adults living with systemic lupus erythematosus: thematic synthesis of qualitative studies. Arthritis Care Res (Hoboken) (2013) 1.53

Time on dialysis and cancer risk after kidney transplantation. Transplantation (2013) 1.53

Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int (2013) 1.52

HMG CoA reductase inhibitors (statins) for kidney transplant recipients. Cochrane Database Syst Rev (2014) 1.52

Cardiac testing for coronary artery disease in potential kidney transplant recipients. Cochrane Database Syst Rev (2011) 1.52

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev (2009) 1.52

Clinical practice guidelines on wait-listing for kidney transplantation: consistent and equitable? Transplantation (2012) 1.50

The cost-effectiveness of increasing kidney transplantation and home-based dialysis. Nephrology (Carlton) (2009) 1.48

Health benefits and costs of screening for colorectal cancer in people on dialysis or who have received a kidney transplant. Nephrol Dial Transplant (2012) 1.48

The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant (2009) 1.48

Factors influencing quality of life in children with urinary incontinence. J Urol (2011) 1.47

Interventions for bone disease in children with chronic kidney disease. Cochrane Database Syst Rev (2010) 1.47

Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura. Cochrane Database Syst Rev (2009) 1.46

Long-term cancer risk of immunosuppressive regimens after kidney transplantation. J Am Soc Nephrol (2010) 1.45

The risk of cancer in recipients of living-donor, standard and expanded criteria deceased donor kidney transplants: a registry analysis. Transplantation (2014) 1.44

Problematic linkage of publicly disclosed hand hygiene compliance and health care-associated Staphylococcus aureus bacteraemia rates. Med J Aust (2012) 1.43

Prognostic value of cardiac tests in potential kidney transplant recipients: a systematic review. Transplantation (2015) 1.43

Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities. PLoS One (2012) 1.42

Children are not just small adults: the urgent need for high-quality trial evidence in children. PLoS Med (2008) 1.41

The relative benefits and costs of solid phase bead technology to detect preformed donor specific antihuman leukocyte antigen antibodies in determining suitability for kidney transplantation. Transplantation (2015) 1.40

The Initiating Dialysis Early and Late (IDEAL) study: study rationale and design. Perit Dial Int (2004) 1.40

Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Cochrane Database Syst Rev (2012) 1.39

Questioning the myth: benefits of renin-angiotensin system blockade in kidney transplant recipients. Transplantation (2014) 1.39

Cost-effectiveness of breast cancer screening in women on dialysis. Am J Kidney Dis (2008) 1.39